News, Analysis & Insights on Nutrition, Supplements, and Health
Updated: AHPA: 'If the ingredient is not lawful, the agency has full authority to remove it from the market'
The FDA’s stance that DMAA is not a dietary ingredient and its urging to consumers to avoid supplements containing the ingredient have been welcomed by key industry stakeholders, including USADA, ABC, UNPA, NPA, and CRN.
Connell Brothers has signed an exclusive agreement with Ganeden Biotech to market the American company’s GanedenBC30 priobiotic across the Asia-Pacific region. Connell plans to begin distribution immediately, beginning with Southeast and North Asia.
We have heard from attorneys representing food and beverage manufacturers about what Judge Richard Seeborg’s decision to throw out a lawsuit vs AriZona Iced Tea could mean for other ‘all-natural’ cases. But what do lawyers representing consumers in such...
Ashwagandha, sometimes called the “king” of ayurvedic herbs, has been gaining traction in the North American marketplace. A big part of the reason is the investments in clinical science and the marketing support made by major suppliers of the...
Lakeview Equity Partners, a Milwaukee-based investment firm, has taken its first dip into the human nutrition pool with the acquisition of probiotics supplier and finished goods manufacturer UAS Labs.
The EU’s science agency has rejected a health claim submission linking omega-3 form EPA (eicosapentaenoic acid) and reduced risk of ADHD in kids.